BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26890408)

  • 1. How to Conduct Store Observations of Tobacco Marketing and Products.
    Feld AL; Johnson TO; Byerly KW; Ribisl KM
    Prev Chronic Dis; 2016 Feb; 13():E25. PubMed ID: 26890408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crowdsourcing data collection of the retail tobacco environment: case study comparing data from crowdsourced workers to trained data collectors.
    Kim AE; Lieberman AJ; Dench D
    Tob Control; 2015 Mar; 24(e1):e6-9. PubMed ID: 24500265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of store audit methods for assessing tobacco marketing and products at the point of sale.
    Lee JG; Henriksen L; Myers AE; Dauphinee AL; Ribisl KM
    Tob Control; 2014 Mar; 23(2):98-106. PubMed ID: 23322313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tapping Into Multiple Data "Springs" to Strengthen Policy Streams: A Guide to the Types of Data Needed to Formulate Local Retail Tobacco Control Policy.
    Myers AE; Knocke K; Leeman J
    Prev Chronic Dis; 2019 Apr; 16():E43. PubMed ID: 30950786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-sale marketing of tobacco products: taking advantage of the socially disadvantaged?
    John R; Cheney MK; Azad MR
    J Health Care Poor Underserved; 2009 May; 20(2):489-506. PubMed ID: 19395844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-purchase tobacco environments and variation by store type--United States, 1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(9):184-7. PubMed ID: 11900352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marketing IQOS in a dark market.
    Mathers A; Schwartz R; O'Connor S; Fung M; Diemert L
    Tob Control; 2019 Mar; 28(2):237-238. PubMed ID: 29724866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waterpipe industry products and marketing strategies: analysis of an industry trade exhibition.
    Jawad M; Nakkash RT; Hawkins B; Akl EA
    Tob Control; 2015 Dec; 24(e4):e275-9. PubMed ID: 26149455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of the tobacco industry documents for public health and policy.
    Bero L
    Annu Rev Public Health; 2003; 24():267-88. PubMed ID: 12415145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marketing cigarettes when all else is unavailable: evidence of discounting in price-sensitive neighbourhoods.
    Burton S; Williams K; Fry R; Chapman K; Soulos G; Tang A; Walsberger S; Egger S
    Tob Control; 2014 May; 23(e1):e24-9. PubMed ID: 24227539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco industry sponsorships: new image belies its deadly product.
    Malone RE
    J Emerg Nurs; 2004 Apr; 30(2):185-7. PubMed ID: 15039681
    [No Abstract]   [Full Text] [Related]  

  • 12. Conducting tobacco industry informant interviews: lessons and implications for commercial determinants of health research.
    Watts C; Burton S; Freeman B
    Health Promot Int; 2022 Apr; 37(2):. PubMed ID: 34634798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corporate social responsibility and the tobacco industry: hope or hype?
    Hirschhorn N
    Tob Control; 2004 Dec; 13(4):447-53. PubMed ID: 15564636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a Multimodal Mobile System for Point-of-Sale Surveillance: Lessons Learned From Case Studies in Washington, DC, and New York City.
    Cantrell J; Ganz O; Ilakkuvan V; Tacelosky M; Kreslake J; Moon-Howard J; Aidala A; Vallone D; Anesetti-Rothermel A; Kirchner TR
    JMIR Public Health Surveill; 2015; 1(2):e20. PubMed ID: 27227138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco point-of-purchase promotion: examining tobacco industry documents.
    Lavack AM; Toth G
    Tob Control; 2006 Oct; 15(5):377-84. PubMed ID: 16998172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the tobacco use epidemic IV. The vector: Tobacco industry data sources and recommendations for research and evaluation.
    Cruz TB
    Prev Med; 2009 Jan; 48(1 Suppl):S24-34. PubMed ID: 18976685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health implications of smokeless tobacco use as a harm reduction strategy.
    Savitz DA; Meyer RE; Tanzer JM; Mirvish SS; Lewin F
    Am J Public Health; 2006 Nov; 96(11):1934-9. PubMed ID: 17018821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of tobacco industry retail marketing activities of reduced harm products.
    Slater S; Giovino G; Chaloupka F
    Nicotine Tob Res; 2008 Jan; 10(1):187-93. PubMed ID: 18188759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco industry direct marketing after the Master Settlement Agreement.
    Lewis MJ; Yulis SG; Delnevo C; Hrywna M
    Health Promot Pract; 2004 Jul; 5(3 Suppl):75S-83S. PubMed ID: 15231100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.